Our research examines diseases involving the heart and blood vessels and seeks innovative ways to treat coronary artery diseases.
Our researchers and other UT colleagues patented a high-tech pacemaker that measures cardiac performance and signals early warning of heart problems.
UT Health San Antonio helped develop the world’s first stent used to treat blood vessel blockages.
Our cardiovascular research explores utilizing biomedical technology to diagnose and treat cardiovascular disease, including the use of nanotechnology in vascular medicine to detect plaque on arterial walls or to measure cardiac performance.
UT Health San Antonio conducts studies involving use of medical devices, gene therapy and echocardiography (ultrasound waves) to improve diagnosis and treatment, and to minimize the incidence of heart attack and heart failure.
The Gorder President’s Endowment will help to find new therapies and cures, shape prevention protocols and ensure access to cutting-edge health care that benefits patients across the life span. UT Health San Antonio’s cadre of adult and pediatric cardiovascular disease physicians are experienced experts in treating the most-complex cases, and are a crucial resource for referrals from San Antonio, South Texas and beyond.